EKSDX
Price
$5.71
Change
+$0.08 (+1.42%)
Updated
Apr 9 closing price
Net Assets
323.11M
HBLYX
Price
$14.24
Change
+$0.37 (+2.67%)
Updated
Apr 9 closing price
Net Assets
11.26B
Ad is loading...

EKSDX vs HBLYX

Header iconEKSDX vs HBLYX Comparison
Open Charts EKSDX vs HBLYXBanner chart's image
Allspring Diversified Income Bldr Adm
Price$5.71
Change+$0.08 (+1.42%)
VolumeN/A
Net Assets323.11M
Hartford Balanced Income Y
Price$14.24
Change+$0.37 (+2.67%)
VolumeN/A
Net Assets11.26B
EKSDX vs HBLYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EKSDX vs. HBLYX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKSDX is a Buy and HBLYX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
HBLYX has more cash in the bank: 11.3B vs. EKSDX (323M). EKSDX pays higher dividends than HBLYX: EKSDX (5.80) vs HBLYX (3.53). EKSDX was incepted earlier than HBLYX: EKSDX (15 years) vs HBLYX (19 years). EKSDX (1.12) is less costly to investors than HBLYX (0.67). EKSDX is a more actively managed with annual turnover of: 67.00 vs. HBLYX (61.00). HBLYX has a lower initial minimum investment than EKSDX: HBLYX (250000) vs EKSDX (1000000). EKSDX annual gain was more profitable for investors over the last year : 3.22 vs. HBLYX (-1.50). EKSDX return over 5 years is better than : 31.15 vs. HBLYX (14.76).
EKSDXHBLYXEKSDX / HBLYX
Total Expense Ratio0.880.67131%
Annual Report Gross Expense Ratio1.120.67167%
Fund Existence15 years19 years-
Gain YTD-2.766-2.722102%
Front LoadN/AN/A-
Min. Initial Investment1000000250000400%
Min. Initial Investment IRAN/AN/A-
Net Assets323M11.3B3%
Annual Yield % from dividends5.803.53164%
Returns for 1 year3.22-1.50-214%
Returns for 3 years11.64-0.31-3,768%
Returns for 5 years31.1514.76211%
Returns for 10 years35.9228.95124%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDFF33.413.01
+9.90%
Fidelity Disruptive Finance ETF
CVLC67.096.00
+9.82%
Calvert US Large-Cp Cor Rspnb ETF
HYT9.250.78
+9.21%
Blackrock Corporate High Yield Fund
XPH38.862.04
+5.54%
SPDR® S&P Pharmaceuticals ETF
RNWZ21.34N/A
N/A
TrueShares Eagle Glbl Rnwbls Engy IncETF